--- title: "AIDX.US (AIDX.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/AIDX.US/news.md" symbol: "AIDX.US" name: "AIDX.US" parent: "https://longbridge.com/en/quote/AIDX.US.md" datetime: "2026-05-21T05:34:08.485Z" locales: - [en](https://longbridge.com/en/quote/AIDX.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/AIDX.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/AIDX.US/news.md) --- # AIDX.US (AIDX.US) — Related News ### [20/20 Biolabs, Inc. 1Q 2026: Revenue $353.38K, EPS ($0.28) — 10-Q Summary](https://longbridge.com/en/news/287114082.md) *2026-05-20T20:21:01.000Z* > 20/20 Biolabs, Inc. reported a revenue decline to $353.38K in Q1 2026, with a net loss of $2.12M and diluted EPS of ($0. ### [20/20 Biolabs | 10-Q: FY2026 Q1 Revenue: USD 353.38 K](https://longbridge.com/en/news/287113798.md) *2026-05-20T20:20:35.000Z* ### [20/20 BioLabs reveals Q1 2026 financials and recent operational advancements.](https://longbridge.com/en/news/287114767.md) *2026-05-20T20:08:00.000Z* > 20/20 BioLabs reported its Q1 2026 financials, highlighting operational advancements. The country's economy grew by 3.5% ### [University of South Carolina licenses PSA Velocity Algorithm exclusively to 20/20 BioLabs in a new deal.](https://longbridge.com/en/news/286102725.md) *2026-05-12T12:32:07.000Z* > University of South Carolina has exclusively licensed the PSA Velocity Algorithm to 20/20 BioLabs. In related news, the ### [HEALWELL AI Announces Conference Call for First Quarter 2026 Financial Results on May 8, 2026 | HWAIF Stock News](https://longbridge.com/en/news/284512576.md) *2026-04-28T23:15:00.000Z* > HEALWELL AI Inc. will hold a conference call on May 8, 2026, at 8:30 am ET to discuss its Fiscal First Quarter 2026 fina ### [20/20 Biolabs 10-K: Revenues $2.05M, Net Loss $(3.74) M](https://longbridge.com/en/news/281252205.md) *2026-03-31T21:35:01.000Z* > 20/20 Biolabs reported fiscal-year revenue of $2.045 million, a 16.7% increase from the previous year, but recorded a ne ### [20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress | AIDX Stock News](https://longbridge.com/en/news/281244863.md) *2026-03-31T12:57:00.000Z* > 20/20 BioLabs reported a 17% revenue increase to $2.0 million for FY 2025, with gross profit rising 68% and gross margin ### [Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test | AIDX Stock News](https://longbridge.com/en/news/280792132.md) *2026-03-27T04:31:00.000Z* > 20/20 BioLabs, Inc. has announced that 18 Maryland fire departments will receive over $520,000 from the Maryland Departm ### [20/20 BioLabs Secure U.S. License For Advanced CKD Prediction Technology](https://longbridge.com/en/news/280475853.md) *2026-03-25T12:50:25.000Z* > 20/20 BioLabs, Inc. has secured an exclusive U.S. license to integrate ROKIT Healthcare's chronic kidney disease (CKD) p